- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Del Global settles SEC dispute
X-ray equipment manufacturer Del Global Technologies has obtained final approval from the Securities and Exchange Commission regarding the settlement of claims against the company in connection with the restatement of financial statements filed by former
X-ray equipment manufacturer Del Global Technologies has obtained final approval from the Securities and Exchange Commission regarding the settlement of claims against the company in connection with the restatement of financial statements filed by former management for the fiscal years 1997 through the third quarter of fiscal 2000. The terms of the settlement are subject to approval by the U.S. District Court for the Southern District of New York. Del Global signed a consent decree with the SEC in December involving payment of a civil penalty of $400,000. The company is primarily engaged in the design, manufacture, and marketing of x-ray systems for the medical and dental markets, as well as high-voltage power conversion subsystems for medical and other industrial applications.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
